Table 1.
Epidemiology and antimicrobial susceptibility testing
| Sample no. | Organism ID | Age (years) | Sex | IMP | MEP | ERT | FEP | CTX | CAZ | GM | AK | CIP | CO | Carbapenemase |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa | ||||||||||||||
| 1 | Klebsiella pneumoniae | 8 | M | R | R | R | R | R | R | S | S | S | S | CTX-M-15 type |
| 2 | P. aeruginosa | 30 | F | R | R | NA | R | R | R | R | R | R | S | VIM type |
| 3 | P. aeruginosa | 35 | M | R | I | R | R | R | R | R | R | S | ampC overexpression | |
| 4 | P. aeruginosa | 61 | M | R | R | S | R | S | S | S | S | S | ||
| 5 | P. aeruginosa | 19 | M | R | R | R | R | R | S | S | S | S | ||
| 6 | P. aeruginosa | 2 | F | R | R | R | R | R | S | S | R | S | ||
| 7 | P. aeruginosa | 3 | F | R | R | R | R | R | S | S | S | S | ||
| 8 | P. aeruginosa | 40 | M | R | R | R | R | R | R | R | R | S | NDM type | |
| 9 | P. aeruginosa | 2 | M | R | R | R | R | R | S | S | S | S | ampC overexpression | |
| 10 | P. aeruginosa | 61 | M | R | R | R | R | R | R | R | R | S | NDM type | |
| 11 | P. aeruginosa | 74 | M | R | R | R | R | R | R | R | R | S | NDM type | |
| 12 | P. aeruginosa | 66 | M | R | R | R | R | R | R | R | R | S | ampC overexpression | |
| 13 | P. aeruginosa | 44 | M | R | R | R | R | R | S | S | R | S | ||
| 14 | P. aeruginosa | 76 | M | R | R | R | R | R | R | R | R | S | NDM type | |
| Carbapenem-susceptible Enterobacteriaceae and P. aeruginosa | ||||||||||||||
| 15 | Escherichia coli | 20 | M | S | S | S | S | S | S | S | S | S | S | NA |
| 16 | E. coli | 56 | F | S | S | S | R | R | R | S | S | R | S | |
| 17 | E. coli | 47 | F | S | S | S | R | R | R | R | S | R | S | |
| 18 | K. pneumoniae | 1 | M | S | S | S | R | R | R | S | S | S | S | |
| 19 | K. pneumoniae | 6 | M | S | S | S | R | R | I | S | S | S | S | |
| 20 | K. pneumoniae | 84 | F | S | S | S | R | R | R | S | S | S | S | |
| 21 | K. pneumoniae | 77 | M | S | S | S | R | R | R | S | S | S | S | |
| 22 | Providencia stuartii | 74 | M | S | S | S | S | R | R | R | S | S | S | |
| 23 | P. aeruginosa | 52 | M | S | S | NA | I | R | S | S | R | I | S | NA |
| 24 | P. aeruginosa | 76 | F | S | S | I | R | R | S | S | S | S | ||
| 25 | P. aeruginosa | 58 | F | S | S | S | R | S | S | S | S | S | ||
| 26 | P. aeruginosa | 30 | M | S | S | S | R | S | S | S | S | S | ||
| 27 | P. aeruginosa | 72 | F | S | S | S | R | S | S | S | S | S | ||
| 28 | P. aeruginosa | 47 | M | S | S | S | S | S | S | S | S | S | ||
| 29 | P. aeruginosa | 84 | F | S | S | S | S | S | S | S | S | S | ||
| 30 | P. aeruginosa | 31 | M | S | S | S | S | S | S | S | S | S | ||
| 31 | P. aeruginosa | 66 | M | S | S | S | R | S | S | S | S | S | ||
AK, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; CO, colistin; CTX, cefotaxime; ERT, ertapenem; FEP, cefepime; GM, gentamicin; IMP, imipenem; MEP, meropenem; NA, not applicable; R, resistant; S, susceptible.